Literature DB >> 29800292

Allosteric Regulation of the Follicle-Stimulating Hormone Receptor.

Selvaraj Nataraja1, Venkataraman Sriraman2, Stephen Palmer1.   

Abstract

Follicle-stimulating hormone receptor (FSHR) belongs to the leucine-rich repeat family of the G protein-coupled receptor (LGR), which includes the glycoprotein hormone receptors luteinizing hormone receptor, thyrotropin receptor, and other LGRs 4, 5, 6, and 7. FSH is the key regulator of folliculogenesis in females and spermatogenesis in males. FSH elicits its physiological response through its cognate receptor on the cell surface. Binding of the hormone FSH to its receptor FSHR brings about conformational changes in the receptor that are transduced through the transmembrane domain to the intracellular region, where the downstream effector interaction takes place, leading to activation of the downstream signaling cascade. Identification of small molecules that could activate or antagonize FSHR provided interesting tools to study the signal transduction mechanism of the receptor. However, because of the nature of the ligand-receptor interaction of FSH-FSHR, which contains multiple sites in the extracellular binding domain, most of the small-molecule modulators of FSHR are unable to bind to the orthosteric site of the receptors. Rather they modulate receptor activation through allosteric sites in the transmembrane region. This review will discuss allosteric modulation of FSHR primarily through the discovery of small-molecule modulators, focusing on current data on the status of development and the utility of these as tools to better understand signaling mechanisms.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29800292     DOI: 10.1210/en.2018-00317

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Commentary on the Recent FSH Collection: Known Knowns and Known Unknowns.

Authors:  Djurdjica Coss
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

2.  Discovery and Preclinical Development of Orally Active Small Molecules that Exhibit Highly Selective Follicle Stimulating Hormone Receptor Agonism.

Authors:  Selva Nataraja; Henry Yu; Joie Guner; Stephen Palmer
Journal:  Front Pharmacol       Date:  2021-01-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.